The economic impact of prematurity and bronchopulmonary dysplasia

Bronchopulmonary dysplasia (BPD) is one of the most serious chronic lung diseases in infancy and one of the most important sequels of premature birth (prevalence of 15–50%). Our objective was to estimate the cost of BPD of one preterm baby, with no other major prematurity-related complications, duri...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of pediatrics 2017-12, Vol.176 (12), p.1587-1593
Hauptverfasser: Álvarez-Fuente, María, Arruza, Luis, Muro, Marta, Zozaya, Carlos, Avila, Alejandro, López-Ortego, Paloma, González-Armengod, Carmen, Torrent, Alba, Gavilán, Jose Luis, del Cerro, María Jesús
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1593
container_issue 12
container_start_page 1587
container_title European journal of pediatrics
container_volume 176
creator Álvarez-Fuente, María
Arruza, Luis
Muro, Marta
Zozaya, Carlos
Avila, Alejandro
López-Ortego, Paloma
González-Armengod, Carmen
Torrent, Alba
Gavilán, Jose Luis
del Cerro, María Jesús
description Bronchopulmonary dysplasia (BPD) is one of the most serious chronic lung diseases in infancy and one of the most important sequels of premature birth (prevalence of 15–50%). Our objective was to estimate the cost of BPD of one preterm baby, with no other major prematurity-related complications, during the first 2 years of life in Spain. Data from the Spanish Ministry of Health regarding costs of diagnosis-related group of preterm birth, hospital admissions and visits, palivizumab administration, and oxygen therapy in the year 2013 were analyzed. In 2013, 2628 preterm babies were born with a weight under 1500 g; 50.9% were males. The need for respiratory support was 2.5% needed only oxygen therapy, 39.5% required conventional mechanical ventilation, and 14.9% required high-frequency ventilation. The incidence of BPD was of 34.9%. The cost of the first 2 years of life of a preterm baby with BPD and no other major prematurity-related complications ranged between 45,049.81 € and 118,760.43 €, in Spain, depending on birth weight and gestational age. If the baby required home oxygen therapy or developed pulmonary hypertension, this cost could add up to 181,742.43 €. Conclusion : Prematurity and BPD have an elevated cost, even for public health care systems. This cost will probably increase in the coming years if the incidence and survival of preterm babies keeps rising. The development of new therapies and preventive strategies to decrease the incidence of BPD and other morbidities associated with prematurity should be a priority. What is known: • Bronchopulmonary dysplasia (BPD) is a serious chronic lung disease related with premature birth. • BPD is an increasing disease due to the up-rise in the number of premature births. What is new: • The economic cost of preterm birth and BPD has never before been estimated in Spain nor published with European data. • Preterm babies with BPD and a good clinical outcome carry also an important economic and social burden.
doi_str_mv 10.1007/s00431-017-3009-6
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1937756838</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1937756838</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-f51ef04097c5bdcd43d999e2a3d749dd9d980c88374fff6cc20a6f4b6fdd0c2d3</originalsourceid><addsrcrecordid>eNp1kLtKBDEUhoMoul4ewEYGbGyiJ5NsLqWINxBs1jpkc3FHZiZjMlPs25tlVxHBKsX5_v_kfAidE7gmAOImAzBKMBCBKYDCfA_NCKM1JiD4PpoBZYA5UeoIHef8ASWjiDxER7WUUhFVz9DtYuUrb2Mfu8ZWTTcYO1YxVEPynRmn1IzryvSuWqbY21UcpraLvUnryq3z0JrcmFN0EEyb_dnuPUFvD_eLuyf88vr4fHf7gi0V9YjDnPgADJSw86WzjlGnlPK1oU4w5ZxySoKVkgoWQuDW1mB4YEsenANbO3qCrra9Q4qfk8-j7ppsfdua3scpa6KoEHMuqSzo5R_0I06pL78rFCeCUUFZociWsinmnHzQQ2q6cpsmoDd-9davLn71xq_mJXOxa56WnXc_iW-hBai3QC6j_t2nX6v_bf0CJO2F2A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1961743734</pqid></control><display><type>article</type><title>The economic impact of prematurity and bronchopulmonary dysplasia</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Álvarez-Fuente, María ; Arruza, Luis ; Muro, Marta ; Zozaya, Carlos ; Avila, Alejandro ; López-Ortego, Paloma ; González-Armengod, Carmen ; Torrent, Alba ; Gavilán, Jose Luis ; del Cerro, María Jesús</creator><creatorcontrib>Álvarez-Fuente, María ; Arruza, Luis ; Muro, Marta ; Zozaya, Carlos ; Avila, Alejandro ; López-Ortego, Paloma ; González-Armengod, Carmen ; Torrent, Alba ; Gavilán, Jose Luis ; del Cerro, María Jesús</creatorcontrib><description>Bronchopulmonary dysplasia (BPD) is one of the most serious chronic lung diseases in infancy and one of the most important sequels of premature birth (prevalence of 15–50%). Our objective was to estimate the cost of BPD of one preterm baby, with no other major prematurity-related complications, during the first 2 years of life in Spain. Data from the Spanish Ministry of Health regarding costs of diagnosis-related group of preterm birth, hospital admissions and visits, palivizumab administration, and oxygen therapy in the year 2013 were analyzed. In 2013, 2628 preterm babies were born with a weight under 1500 g; 50.9% were males. The need for respiratory support was 2.5% needed only oxygen therapy, 39.5% required conventional mechanical ventilation, and 14.9% required high-frequency ventilation. The incidence of BPD was of 34.9%. The cost of the first 2 years of life of a preterm baby with BPD and no other major prematurity-related complications ranged between 45,049.81 € and 118,760.43 €, in Spain, depending on birth weight and gestational age. If the baby required home oxygen therapy or developed pulmonary hypertension, this cost could add up to 181,742.43 €. Conclusion : Prematurity and BPD have an elevated cost, even for public health care systems. This cost will probably increase in the coming years if the incidence and survival of preterm babies keeps rising. The development of new therapies and preventive strategies to decrease the incidence of BPD and other morbidities associated with prematurity should be a priority. What is known: • Bronchopulmonary dysplasia (BPD) is a serious chronic lung disease related with premature birth. • BPD is an increasing disease due to the up-rise in the number of premature births. What is new: • The economic cost of preterm birth and BPD has never before been estimated in Spain nor published with European data. • Preterm babies with BPD and a good clinical outcome carry also an important economic and social burden.</description><identifier>ISSN: 0340-6199</identifier><identifier>EISSN: 1432-1076</identifier><identifier>DOI: 10.1007/s00431-017-3009-6</identifier><identifier>PMID: 28889192</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Babies ; Birth weight ; Bronchopulmonary Dysplasia - economics ; Bronchopulmonary Dysplasia - epidemiology ; Bronchopulmonary Dysplasia - therapy ; Child, Preschool ; Databases, Factual ; Dysplasia ; Female ; Follow-Up Studies ; Gestational age ; Health Care Costs - statistics &amp; numerical data ; Humans ; Incidence ; Infant ; Infant, Newborn ; Infant, Premature ; Lung diseases ; Male ; Mechanical ventilation ; Medicine ; Medicine &amp; Public Health ; Monoclonal antibodies ; Neonates ; Original Article ; Oxygen ; Oxygen therapy ; Pediatrics ; Premature birth ; Public health ; Respiratory therapy ; Spain - epidemiology ; Ventilation</subject><ispartof>European journal of pediatrics, 2017-12, Vol.176 (12), p.1587-1593</ispartof><rights>Springer-Verlag GmbH Germany 2017</rights><rights>European Journal of Pediatrics is a copyright of Springer, (2017). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-f51ef04097c5bdcd43d999e2a3d749dd9d980c88374fff6cc20a6f4b6fdd0c2d3</citedby><cites>FETCH-LOGICAL-c372t-f51ef04097c5bdcd43d999e2a3d749dd9d980c88374fff6cc20a6f4b6fdd0c2d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00431-017-3009-6$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00431-017-3009-6$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28889192$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Álvarez-Fuente, María</creatorcontrib><creatorcontrib>Arruza, Luis</creatorcontrib><creatorcontrib>Muro, Marta</creatorcontrib><creatorcontrib>Zozaya, Carlos</creatorcontrib><creatorcontrib>Avila, Alejandro</creatorcontrib><creatorcontrib>López-Ortego, Paloma</creatorcontrib><creatorcontrib>González-Armengod, Carmen</creatorcontrib><creatorcontrib>Torrent, Alba</creatorcontrib><creatorcontrib>Gavilán, Jose Luis</creatorcontrib><creatorcontrib>del Cerro, María Jesús</creatorcontrib><title>The economic impact of prematurity and bronchopulmonary dysplasia</title><title>European journal of pediatrics</title><addtitle>Eur J Pediatr</addtitle><addtitle>Eur J Pediatr</addtitle><description>Bronchopulmonary dysplasia (BPD) is one of the most serious chronic lung diseases in infancy and one of the most important sequels of premature birth (prevalence of 15–50%). Our objective was to estimate the cost of BPD of one preterm baby, with no other major prematurity-related complications, during the first 2 years of life in Spain. Data from the Spanish Ministry of Health regarding costs of diagnosis-related group of preterm birth, hospital admissions and visits, palivizumab administration, and oxygen therapy in the year 2013 were analyzed. In 2013, 2628 preterm babies were born with a weight under 1500 g; 50.9% were males. The need for respiratory support was 2.5% needed only oxygen therapy, 39.5% required conventional mechanical ventilation, and 14.9% required high-frequency ventilation. The incidence of BPD was of 34.9%. The cost of the first 2 years of life of a preterm baby with BPD and no other major prematurity-related complications ranged between 45,049.81 € and 118,760.43 €, in Spain, depending on birth weight and gestational age. If the baby required home oxygen therapy or developed pulmonary hypertension, this cost could add up to 181,742.43 €. Conclusion : Prematurity and BPD have an elevated cost, even for public health care systems. This cost will probably increase in the coming years if the incidence and survival of preterm babies keeps rising. The development of new therapies and preventive strategies to decrease the incidence of BPD and other morbidities associated with prematurity should be a priority. What is known: • Bronchopulmonary dysplasia (BPD) is a serious chronic lung disease related with premature birth. • BPD is an increasing disease due to the up-rise in the number of premature births. What is new: • The economic cost of preterm birth and BPD has never before been estimated in Spain nor published with European data. • Preterm babies with BPD and a good clinical outcome carry also an important economic and social burden.</description><subject>Babies</subject><subject>Birth weight</subject><subject>Bronchopulmonary Dysplasia - economics</subject><subject>Bronchopulmonary Dysplasia - epidemiology</subject><subject>Bronchopulmonary Dysplasia - therapy</subject><subject>Child, Preschool</subject><subject>Databases, Factual</subject><subject>Dysplasia</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Gestational age</subject><subject>Health Care Costs - statistics &amp; numerical data</subject><subject>Humans</subject><subject>Incidence</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Infant, Premature</subject><subject>Lung diseases</subject><subject>Male</subject><subject>Mechanical ventilation</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Monoclonal antibodies</subject><subject>Neonates</subject><subject>Original Article</subject><subject>Oxygen</subject><subject>Oxygen therapy</subject><subject>Pediatrics</subject><subject>Premature birth</subject><subject>Public health</subject><subject>Respiratory therapy</subject><subject>Spain - epidemiology</subject><subject>Ventilation</subject><issn>0340-6199</issn><issn>1432-1076</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kLtKBDEUhoMoul4ewEYGbGyiJ5NsLqWINxBs1jpkc3FHZiZjMlPs25tlVxHBKsX5_v_kfAidE7gmAOImAzBKMBCBKYDCfA_NCKM1JiD4PpoBZYA5UeoIHef8ASWjiDxER7WUUhFVz9DtYuUrb2Mfu8ZWTTcYO1YxVEPynRmn1IzryvSuWqbY21UcpraLvUnryq3z0JrcmFN0EEyb_dnuPUFvD_eLuyf88vr4fHf7gi0V9YjDnPgADJSw86WzjlGnlPK1oU4w5ZxySoKVkgoWQuDW1mB4YEsenANbO3qCrra9Q4qfk8-j7ppsfdua3scpa6KoEHMuqSzo5R_0I06pL78rFCeCUUFZociWsinmnHzQQ2q6cpsmoDd-9davLn71xq_mJXOxa56WnXc_iW-hBai3QC6j_t2nX6v_bf0CJO2F2A</recordid><startdate>20171201</startdate><enddate>20171201</enddate><creator>Álvarez-Fuente, María</creator><creator>Arruza, Luis</creator><creator>Muro, Marta</creator><creator>Zozaya, Carlos</creator><creator>Avila, Alejandro</creator><creator>López-Ortego, Paloma</creator><creator>González-Armengod, Carmen</creator><creator>Torrent, Alba</creator><creator>Gavilán, Jose Luis</creator><creator>del Cerro, María Jesús</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20171201</creationdate><title>The economic impact of prematurity and bronchopulmonary dysplasia</title><author>Álvarez-Fuente, María ; Arruza, Luis ; Muro, Marta ; Zozaya, Carlos ; Avila, Alejandro ; López-Ortego, Paloma ; González-Armengod, Carmen ; Torrent, Alba ; Gavilán, Jose Luis ; del Cerro, María Jesús</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-f51ef04097c5bdcd43d999e2a3d749dd9d980c88374fff6cc20a6f4b6fdd0c2d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Babies</topic><topic>Birth weight</topic><topic>Bronchopulmonary Dysplasia - economics</topic><topic>Bronchopulmonary Dysplasia - epidemiology</topic><topic>Bronchopulmonary Dysplasia - therapy</topic><topic>Child, Preschool</topic><topic>Databases, Factual</topic><topic>Dysplasia</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Gestational age</topic><topic>Health Care Costs - statistics &amp; numerical data</topic><topic>Humans</topic><topic>Incidence</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Infant, Premature</topic><topic>Lung diseases</topic><topic>Male</topic><topic>Mechanical ventilation</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Monoclonal antibodies</topic><topic>Neonates</topic><topic>Original Article</topic><topic>Oxygen</topic><topic>Oxygen therapy</topic><topic>Pediatrics</topic><topic>Premature birth</topic><topic>Public health</topic><topic>Respiratory therapy</topic><topic>Spain - epidemiology</topic><topic>Ventilation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Álvarez-Fuente, María</creatorcontrib><creatorcontrib>Arruza, Luis</creatorcontrib><creatorcontrib>Muro, Marta</creatorcontrib><creatorcontrib>Zozaya, Carlos</creatorcontrib><creatorcontrib>Avila, Alejandro</creatorcontrib><creatorcontrib>López-Ortego, Paloma</creatorcontrib><creatorcontrib>González-Armengod, Carmen</creatorcontrib><creatorcontrib>Torrent, Alba</creatorcontrib><creatorcontrib>Gavilán, Jose Luis</creatorcontrib><creatorcontrib>del Cerro, María Jesús</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pediatrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Álvarez-Fuente, María</au><au>Arruza, Luis</au><au>Muro, Marta</au><au>Zozaya, Carlos</au><au>Avila, Alejandro</au><au>López-Ortego, Paloma</au><au>González-Armengod, Carmen</au><au>Torrent, Alba</au><au>Gavilán, Jose Luis</au><au>del Cerro, María Jesús</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The economic impact of prematurity and bronchopulmonary dysplasia</atitle><jtitle>European journal of pediatrics</jtitle><stitle>Eur J Pediatr</stitle><addtitle>Eur J Pediatr</addtitle><date>2017-12-01</date><risdate>2017</risdate><volume>176</volume><issue>12</issue><spage>1587</spage><epage>1593</epage><pages>1587-1593</pages><issn>0340-6199</issn><eissn>1432-1076</eissn><abstract>Bronchopulmonary dysplasia (BPD) is one of the most serious chronic lung diseases in infancy and one of the most important sequels of premature birth (prevalence of 15–50%). Our objective was to estimate the cost of BPD of one preterm baby, with no other major prematurity-related complications, during the first 2 years of life in Spain. Data from the Spanish Ministry of Health regarding costs of diagnosis-related group of preterm birth, hospital admissions and visits, palivizumab administration, and oxygen therapy in the year 2013 were analyzed. In 2013, 2628 preterm babies were born with a weight under 1500 g; 50.9% were males. The need for respiratory support was 2.5% needed only oxygen therapy, 39.5% required conventional mechanical ventilation, and 14.9% required high-frequency ventilation. The incidence of BPD was of 34.9%. The cost of the first 2 years of life of a preterm baby with BPD and no other major prematurity-related complications ranged between 45,049.81 € and 118,760.43 €, in Spain, depending on birth weight and gestational age. If the baby required home oxygen therapy or developed pulmonary hypertension, this cost could add up to 181,742.43 €. Conclusion : Prematurity and BPD have an elevated cost, even for public health care systems. This cost will probably increase in the coming years if the incidence and survival of preterm babies keeps rising. The development of new therapies and preventive strategies to decrease the incidence of BPD and other morbidities associated with prematurity should be a priority. What is known: • Bronchopulmonary dysplasia (BPD) is a serious chronic lung disease related with premature birth. • BPD is an increasing disease due to the up-rise in the number of premature births. What is new: • The economic cost of preterm birth and BPD has never before been estimated in Spain nor published with European data. • Preterm babies with BPD and a good clinical outcome carry also an important economic and social burden.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>28889192</pmid><doi>10.1007/s00431-017-3009-6</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0340-6199
ispartof European journal of pediatrics, 2017-12, Vol.176 (12), p.1587-1593
issn 0340-6199
1432-1076
language eng
recordid cdi_proquest_miscellaneous_1937756838
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Babies
Birth weight
Bronchopulmonary Dysplasia - economics
Bronchopulmonary Dysplasia - epidemiology
Bronchopulmonary Dysplasia - therapy
Child, Preschool
Databases, Factual
Dysplasia
Female
Follow-Up Studies
Gestational age
Health Care Costs - statistics & numerical data
Humans
Incidence
Infant
Infant, Newborn
Infant, Premature
Lung diseases
Male
Mechanical ventilation
Medicine
Medicine & Public Health
Monoclonal antibodies
Neonates
Original Article
Oxygen
Oxygen therapy
Pediatrics
Premature birth
Public health
Respiratory therapy
Spain - epidemiology
Ventilation
title The economic impact of prematurity and bronchopulmonary dysplasia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T19%3A03%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20economic%20impact%20of%20prematurity%20and%20bronchopulmonary%20dysplasia&rft.jtitle=European%20journal%20of%20pediatrics&rft.au=%C3%81lvarez-Fuente,%20Mar%C3%ADa&rft.date=2017-12-01&rft.volume=176&rft.issue=12&rft.spage=1587&rft.epage=1593&rft.pages=1587-1593&rft.issn=0340-6199&rft.eissn=1432-1076&rft_id=info:doi/10.1007/s00431-017-3009-6&rft_dat=%3Cproquest_cross%3E1937756838%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1961743734&rft_id=info:pmid/28889192&rfr_iscdi=true